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Abstract
Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a group of rare autoimmune diseases. Although the
aetiology of AAV is uncertain, it is likely that genetic and environmental factors contribute. We report the unusual case of two
brothers presenting with AAV with differing clinical pictures and differing ANCA speciﬁcity. There is a recently identiﬁed
difference in genetic risk factors associated with ANCA speciﬁcity, making it surprising that ﬁrst-degree relatives develop AAV
with differing clinical and serological features. Our report illustrates the complex aetiology of AAV and suggests that further
research on the interaction of genetic and environmental factors is needed.
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Background
Anti-neutrophil cytoplasm antibody (ANCA)-associated vascu-
litis (AAV) is the term used to describe a group of systemic
diseases characterized by small vessel vasculitis [1]. There are
three clinical syndromes: granulomatosis with polyangitis
(GPA); microscopic polyangitis (MPA); and eosinophilic granulo-
matosis with polyangitis (EGPA). Within a Caucasian population,
GPA is usually associated with antibodies against proteinase-3
(PR3), MPA is usually associated with antibodies against myelo-
peroxidase (MPO) and EGPA is often associated with anti-MPO
antibodies but is sometimesANCAnegative. Renal limited vascu-
litis is also recognized with either antibody speciﬁcity. These are
rare conditions with an annual incidence of around 20 cases per
million within the UK [2]. They are often associated with signiﬁ-
cant morbidity and mortality despite progress in immunosup-
pressive regimens designed to maximize efﬁciency and limit
toxicity [3]. The aetiology of AAV remains uncertain; however, it
is likely that both genetic predisposition and environmental trig-
gers are important. There is also mounting evidence for the
pathogenicity of ANCA [4]. We report the very unusual occur-
rence of two brothers with AAV, but with differing clinical syn-
dromes and ANCA types.
Case reports
Patient 1
A 49-year-old Caucasian man presented as an emergency with a
1 day history of severe epistaxis. He had a 3-month history of
nasal congestion, left ear and supraorbital pain, and lethargy.
On examination he had bilateral uveitis and episcleritis and a
faint purpuric rash over his groin. Flexible nasendoscopy demon-
strated copious dried blood and secretions. Urine dipstick
showed 4+ blood and 4+ protein.
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Investigations showed preserved renal function, creatinine
91 µmol/L and mild anaemia, haemoglobin 12 g/dL. Inﬂamma-
tory markers were raised, C-reactive protein 368 mg/L and
erythrocyte sedimentation rate 119 mm/h. Computed tomog-
raphy (CT) chest demonstrated diffuse ground glass inﬁltrates
throughout both lung ﬁelds (Figure 1). CT sinuses showed diffuse
mucosal thickening of the maxillary sinuses. A diagnosis of
probable vasculitis was made and the patient was started on
30 mg/day of oral prednisolone. Hewas found to be C-ANCA posi-
tivewith anti-PR3 titre of 431 IU (normal range <25). He developed
haemoptysis with a fall in his haemoglobin to 10.5 g/dL, and
acute kidney injury with peak creatinine 185 µmol/L. Nasal
swabs were negative for methicillin-resistant staphylococcal
aureus but were not tested for methicillin-sensitive staphylococ-
cal aureus.
The diagnosis of GPAwasmade and hewas transferred to our
centre and treated by our current protocol for vasculitis with pul-
monary haemorrhage. He received 60 mg/day oral prednisolone,
1 g IV cyclophosphamide and ten 4 L plasma exchanges. Renal
biopsy was not performed because of the urgency of starting
treatment. Following discharge he received ﬁve further doses of
IV cyclophosphamide (total 4 g) and 2× 1 g IV rituximab (again
in keeping with our current protocol). Prednisolone was weaned
gradually and stopped by 9 months as he became Cushingoid.
He was maintained on azathioprine alone at a dose of 150 mg
once daily. He had some minor infective complications with
recurrent dental infections due to underlying dental caries
which resolved following tooth extraction. Two and a half years
later he is in complete remission with a creatinine of 82 µmol/L,
although he remains C-ANCApositivewith anti-PR3 titre of 70 IU.
Patient 2
Six months later the patient’s brother presented at the age of
53 yearswith 6weeks ofworsening lethargy,myalgia and arthral-
gia. He had a dry cough but no haemoptysis, and weight loss of
10 kg. Urine dipstick showed 3+ blood and 1+ protein. Investiga-
tions showed acute kidney injury, creatinine 338 µmol/L (no
baseline available but 213 µmol/L when checked by his general
practitioner 2 days previously). He was P-ANCA positive with
anti-MPO titre of 357 IU (normal range <25). CT chest was unre-
markable except for a single pulmonary nodule which did not
meet criteria for further investigation. Renal biopsy showed
pauci-immune crescentic glomerulonephritis and necrotizing
vasculitis (Figure 2).
The diagnosis of MPA was made, and he was treated with
60 mg/day oral prednisolone, 1 g IV rituximab and 750 mg IV
cyclophosphamide. Following discharge he received a further
1 g IV rituximab and ﬁve further doses of IV cyclophosphamide
(total 3.5 g) and was maintained on low-dose oral prednisolone
(5 mg/day) and azathioprine 75 mg/day. His treatment was by
our current protocol for treatment of patients with vasculitis
but not requiring dialysis and without pulmonary haemorrhage.
His treatment course was uneventful with no infectious compli-
cations. He remains in remission 2 years later with stable renal
function (creatinine 140 µmol/L) although still P-ANCA positive
with anti-MPO titre of 40 IU.
Discussion
We describe the occurrence of two different ANCA-associated
vasculitides, GPA and MPA, in two brothers who were brought
up together in West London. They presented within 6 months
of each other with distinct clinical pictures and differing ANCA
speciﬁcity. One brother had renal, pulmonary, and ear, nose
and throat (ENT) involvement with positive PR3-ANCA typical
of GPA, and the other brother had positiveMPO-ANCA and clinic-
al features in keeping with MPA. They had no signiﬁcant family
history, in particular no history of vasculitis or autoimmune dis-
ease. The brothers have a sharedHLAhaplotype ofA*3, B*44, Cw7,
DR*11, DQ*7, DQB1*03/05, which to our knowledge has not been
reported to be associated with AAV.
There are few previous reports of familial AAV. The majority
describe familial clusters of patients presenting separated in
time, but with similar clinical phenotypes and the same ANCA
type. We previously reported three members of an Indo-Asian
family with GPA who all presented with ENT and renal involve-
ment [5]. Hay et al. [6] reported on two siblings with GPA, both
with renal and pulmonary involvement, and Sewell and Hamil-
ton [7] reported a mother and daughter with GPA, both with
ENT and renal involvement. There are even fewer reported
cases of ﬁrst-degree relatives presentingwith small vessel vascu-
litis with different ANCA types. A family reported by Gomes et al.
[8] includes a father and daughter who both presented with renal
disease; one was anti-PR3 positive and the other anti-MPO posi-
tive. Manganelli et al. [9] reported two brothers with EGPA (ANCA
negative) and GPA (anti-PR3 positive).
AAV is known to have important genetic associations. A gen-
ome-wide association study [10] identiﬁed four single nucleotide
polymorphisms (SNPs) that associated with AAV. GPA/PR3-ANCA
Fig. 1. CT chest image from Patient 1 showing bilateral diffuse ground glass
inﬁltrates.
Fig. 2. Renal biopsy from Patient 2. Silver stain showing glomerulus with cellular
crescent formation (courtesy of Professor Terry Cook).
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associated with SNPs within HLA-DP, SERPINA1 (which encodes
α1-antitrypsin) and PRTN3 (which encodes proteinase 3), where-
as a SNP within HLA-DQ associated with MPA/MPO-ANCA. Fur-
ther analysis showed that these SNPs were more strongly
associated with ANCA type than with clinical phenotype, sug-
gesting that these diseases should perhaps be re-classiﬁed as
PR3-ANCA or MPO-ANCA vasculitis, rather than GPA or MPA.
Environmental factors are also likely to be important in the
pathogenesis of AAV and a variety of toxins, infections and
drugs have been implicated [3]. Silica is the environmental
toxin for which there is the greatest evidence, with a population
case–control study showing high lifetime silica exposure asso-
ciated with AAV [11]. Brener et al. [12] reported the case of two
brothers with pulmonary and renal vasculitis (anti-MPO posi-
tive); both brothers had been exposed to silica but four other un-
exposed siblings did not have vasculitis. Neither of our patients
reported exposure to any environmental factor which could
have predisposed them to developing AAV.
Given the identiﬁcation of a difference in genetic risk factors
associated with different AAV phenotypes and ANCA speciﬁcity
it is perhaps surprising that ﬁrst-degree relatives develop AAV
with differing clinical and serological features. It may be that
there was some unrecognized environmental exposure, such as
a toxin or infection, within their shared upbringing. Our report il-
lustrates the complex aetiology of AAV and suggests that further
research on the interaction of genetic and environmental factors
is needed.
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